Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Pharm Sci ; 106(4): 1183-1186, 2017 04.
Artigo em Inglês | MEDLINE | ID: mdl-28057543

RESUMO

The high-throughput in vitro intestinal lipolysis model (HTP) applicable for rapid and low-scale screening of lipid-based drug delivery systems (LbDDSs) was optimized and adjusted as to be conducted in 96-well plates (HTP-96). Three different LbDDSs (I-III) loaded with danazol or cinnarizine were used as model systems. The distributions of cinnarizine and danazol in the aqueous and precipitated digestion phases generated during lipolysis in HTP-96 were compared with previously published data obtained from HTP. The final HTP-96 setup resulted in the same rank order as the original HTP model with regard to solubilization in the aqueous phase during digestion: LbDDS III > LbDDS II > LbDDS I for danazol and LbDDS III ≈ LbDDS II ≈ LbDDS I for cinnarizine. HTP-96 is a useful model for fast performance assessment of LbDDS in a small scale.


Assuntos
Cinarizina/metabolismo , Danazol/metabolismo , Sistemas de Liberação de Medicamentos/métodos , Ensaios de Triagem em Larga Escala/métodos , Metabolismo dos Lipídeos/fisiologia , Lipólise/fisiologia , Modelos Biológicos , Cinarizina/administração & dosagem , Danazol/administração & dosagem , Metabolismo dos Lipídeos/efeitos dos fármacos , Lipídeos/administração & dosagem , Lipólise/efeitos dos fármacos , Fatores de Tempo
2.
Mol Pharm ; 12(11): 4067-76, 2015 Nov 02.
Artigo em Inglês | MEDLINE | ID: mdl-26393273

RESUMO

The aim of this study was to investigate if molecular interactions between the weak base cinnarizine and lipolysis products were affecting the morphology of precipitated drug formed during in vitro lipolysis. In vitro lipolysis studies of a self-nanoemulsifying drug delivery system with or without cinnarizine were conducted. The digestion phases (aqueous phase and pellet phase) were separated by ultracentrifugation, and the pellet was isolated and lyophilized. The lyophilized pellets were examined by X-ray powder diffraction, (13)C solid-state nuclear magnetic resonance ((13)C NMR), (1)H liquid-state NMR ((1)H NMR) spectroscopy and differential scanning calorimetry (DSC). The (13)C NMR data indicated that the carbonyl groups and aliphatic part of the lipids undergo structural changes when the pellet contains cinnarizine. The (1)H NMR data suggests interactions occurring around the nitrogens on cinnarizine and the carboxylic group of fatty acids. DSC thermograms showed cinnarizine to be homogeneously incorporated into the lipids of the pellet, and no free amorphous cinnarizine was present. The three techniques (13)C NMR, (1)H NMR, and DSC complement each other and suggest interactions to occur between fatty acids and cinnarizine, which in turn favors amorphous precipitation.


Assuntos
Bloqueadores dos Canais de Cálcio/química , Precipitação Química , Cinarizina/química , Sistemas de Liberação de Medicamentos , Lipídeos/química , Varredura Diferencial de Calorimetria , Química Farmacêutica , Portadores de Fármacos , Lipólise , Solubilidade , Fatores de Tempo
3.
Eur J Pharm Biopharm ; 94: 493-500, 2015 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-26159837

RESUMO

PURPOSE: To develop a high-throughput in vitro intestinal lipolysis (HTP) model, without any means of pH-stat-titration, to enable a fast evaluation of lipid-based drug delivery systems (LbDDS). MATERIAL AND METHOD: The HTP model was compared to the traditionally used dynamic in vitro lipolysis (DIVL) model with regard to the extent of lipid digestion and drug distribution of two poorly soluble model drugs (cinnarizine and danazol), during digestion of three LbDDS (LbDDS I-III). RESULT: The HTP model was able to maintain pH around 6.5 during digestion, without the addition of NaOH to neutralize the free fatty acids (FFAs), due to an increased buffer capacity. Cinnarizine was primarily located in the aqueous phase during digestion of all three LbDDS and did not differ significantly between the two models. The distribution of danazol varied from formulation to formulation, but no significant difference between the models was observed. The triacylglycerides (TAG) in LbDDS III were digested to the same extent in both models, whereas the TAG present in LbDDS II was digested slightly less in the HTP model. No TAG was present in LbDDS I and digestion was therefore not analyzed. CONCLUSION: The HTP model is able to predict drug distribution during digestion of LbDDS containing poorly water soluble drugs in the same manner as the DIVL model. Thus the HTP model might prove applicable for high-throughput evaluation of LbDDS in e.g. 96 well plates or small scale dissolution equipment.


Assuntos
Portadores de Fármacos/química , Ensaios de Triagem em Larga Escala/métodos , Mucosa Intestinal/metabolismo , Lipídeos/química , Lipólise , Modelos Biológicos , Cromatografia Líquida de Alta Pressão , Cinarizina/administração & dosagem , Cinarizina/química , Cinarizina/farmacocinética , Danazol/administração & dosagem , Danazol/química , Danazol/farmacocinética , Portadores de Fármacos/farmacocinética , Cinética , Tamanho da Partícula
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...